(a) Immunoblot of lysates from paired breast cancer patient non-tumor (N) and tumor (T) tissues. (b) Immunoblot of T47D cells infected with lentivirus encoding METTL3 shRNA or control shRNA by …
Unedited western blot images for Figure 1.
Immunoblot of lysates from lung cancer cells (a) or renal cancer cells (b) or HCT116 and MEF cells (c).
Unedited western blot images for Figure 1—figure supplement 1.
Sequence alignments of the conserved residues on (234–244) (a) and (192–201) (c) of METTL3. (b, d) Immunoblot of 293T cells transfected with empty vector (Vec) or METTL3-WT (wild-type) or the …
Unedited western blot images for Figure 2.
Table related to Figure 2i.
Immunofluorescence analysis of T47D cells stably expressing METTL3-WT or mutants under METTL3 knockout. Scale bars, 10 μm.
Images related to Figure 2—figure supplement 1.
(a) Purified recombinant METTL3-WT-His, METTL3-Δ198, METTL3-Δ238, or METTL3-(Δ198+Δ238)-His protein were incubated with or without T47D cell lysates at 37°C for 1 hr followed by immunoblot with …
Unedited western blot images for Figure 2—figure supplement 2a–d, f–h, and j–l.
Table related to Figure 2—figure supplement 2i.
Immunoblot (a) and cell proliferation (b) of T47D cells infected with retrovirus encoding sgMETTL3 resistant METTL3 variants or control vector (Vec) followed by another infection with sgMETTL3 or …
Unedited western blot images for Figure 3a, c, e, and g and picture related to Figure 3j.
Tables related to Figure 3b, d, f, h, i, and k.
Co-immunoprecipitation analyses of T47D cells (a) and 293T cells (b) transfected with Vector (Vec), METTL3-WT or its mutants. (c) Immunoblot analysis of 293T cells infected with or without …
Unedited western blot images for Figure 4.
(a) Immunoblot of whole cell extracts (WCE) and immunoprecipitations (IP) of 293T transfected with METTL3 containing different tag. (b) Immunoblot analysis showing the binding between purified …
Unedited western blot images for Figure 5a–c, e–l, and n.
Tables related to Figure 5m and o.
(a–d) Immunoblot of whole cell extracts (WCE) and immunoprecipitations (IP) of 293T cells infected with lentivirus encoding METLL3 shRNA followed by transfection with the mutants of METTL3 as …
Unedited western blot images for Figure 5—figure supplement 1.
(a) Cumulative distribution function of log2 peak intensity of m6A-modified sites in T47D cells infected with retrovirus encoding sgMETTL3 resistant METTL3-WT, METTL3-Δ198, METTL3-Δ238, or control …
Unedited western blot images for Figure 6e, h, and i.
Tables related to Figure 6c, d, g, j.
Consensus motifs (a), and the distribution (b) of m6A-modified sites in T47D cells infected with retrovirus encoding sgMETTL3 resistant METTL3-WT, METTL3-Δ198, METTL3-Δ238, or control vector (Vec) …
Unedited western blot images for Figure 6—figure supplement 1d.
Table related Figure 6—figure supplement 1c.
(a) Immunoblot of T47D cells treated with indicated inhibitors. Immunoblot of T47D (b) and MDA-MB-231 (c) cells treated with MG132 for 8 hr. (d) Immunoblot of T47D cells infected with METTL3-Flag …
Unedited western blot images for Figure 7.
(a) Information on protease inhibitors utilized in Figure 7a. Immunoblot analyses of T47D cells (b) or MDA-MB-231(c) cells infected with shControl, shRaptor, or shRictor.
Unedited western blot images for Figure 7—figure supplement 1b and c.